Chesapeake — Debt Investor Presentation (August 2006)
41 slides from Chesapeake's debt investor presentation, Aug 10, 2006
Slide 1: Chesapeake Corp. Lender Presentation
Exhibit 99.1 Chesapeake Corp. Lender Presentation 1 August 9, 2006
Slide 2: Disclaimer
Disclaimer This presentation includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Changes in the following important factors, among others, could cause Chesapeake’s actual results to differ materially from t
Slide 3: Agenda
Agenda Wachovia Securities Welcome Address Andrew Kohut Company Overview CEO & President Market Overview Joel Mostrom Historical Financial Summary Senior Vice President & CFO Cash Flow & Profitability Initiatives Management Team Conclusion / Q&A Wachovia Securities Credit Facilities Candace Formacek
Slide 4: Company Overview
ot ia ~~ Company Overview
Slide 5: Business Summary
Business Summary • A leading supplier of value-added, specialty paperboard packaging in Europe • A leading supplier of specialty plastic packaging products to niche end- use markets • Focus on higher growth, lower cyclicality end-use markets that require rigorous process & quality control, brand pos
Slide 6: A Leading Producer of Value-Added, Specialty Packaging Products
A Leading Producer of Value-Added, Specialty Packaging Products Paperboard Packaging Plastic Packaging Revenue Contribution: 83% of FY 2005 Revenue 17% of FY 2005 Revenue Products & Services: Folding cartons, booklets, leaflets, HDPE bottles, closures and labels, composite tubes, rigid set-up contai
Slide 7: A Leading W. European Paper-based Specialty Packaging Company
A Leading W. European Paper-based Specialty Packaging Company Folding CartonsLabels and Leaflets Mayr Melnhof Chesapeake MeadWestvaco MY Holdings VGB A&R Amcor Edelmann Reno de Medici Graphic Packaging 0 100 200 300 400 500 600 700 800 900 Sales - $ in millions Note: Based on estimated 2004 sales va
Slide 8: Broad Specialty Packaging Portfolio
Broad Specialty Packaging Portfolio 8
Slide 9: Innovative, Design Focused Packaging Solutions
Innovative, Design Focused Packaging Solutions Our award winning design teams work with customers to develop innovative solutions for technically demanding or brand focused packaging applications • Created a striking six-color • Partnered with GlaxoSmithKline in • Produced a “Fairy Tale” vodka pack
Slide 10: Diversified Across Markets & Geographies
Diversified Across Markets & Geographies 2005 Sales by Market 2005 Sales by Geography South Africa Other Plastics Pharma- Belgium 4% 4% 17% Healthcare 36% 6% Ireland 8% Germany Tobacco 12% 13% United States 3% France 11% 34% United Kingdom Branded Products 52% (Alcoholic Drinks, Confectioneries & Co
Slide 11: Long-Standing Relationships with Blue Chip Customers
Long-Standing Relationships with Blue Chip Customers 11
Slide 12: Why We Are Successful
Why We Are Successful Comprehensive Design Expertise Significant investment in design capabilities Collaborative design relationship with customers + Broad Network of State-of-the-Art Facilities & Long-term Customer Relationships 48 sector-focused, efficient manufacturing facilities Strategically lo
Slide 13: Market Overview
4 (4 -— Market Overview
Slide 14: Pharmaceuticals & Healthcare Market
Pharmaceuticals & 36% Healthcare Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increasing use of lifestyle drugs • Comprehensive design services • Aging population • Special packaging features • Increasing OTC drug sales •
Slide 15: Branded Products Market
Branded Products 34% Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increased consumer marketing • Brand positioning/differentiation in focus on promotional discerning global markets packaging • Multi-substrate capabilities
Slide 16: Tobacco Market
13% Tobacco Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Good growth projected in • Supplier rationalization developing countries • Shift from soft to hard pack • Low/negative growth in • Advertising restrictions lead to
Slide 17: Plastics Market
17% Plastics Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increased soft drink and • Lighter weight containers for mineral water consumption agrochemicals and other specialty • Barrier containers for chemicals with superi
Slide 18: #1 Focus is to Increase Cash Flow & Profitability
#1 Focus is to Increase Cash Flow & Profitability Cost Savings Program - $25 million Cost of Capital - Refinancing resulting in $3 million plus in annual interest savings Proactive Management of Legacy Pension Obligations Increased Organic Growth - Worldwide Cash Flow pharmaceutical packaging demand
Slide 19: Historical Financial Summary
Historical Financial Summary 19
Slide 20: Key Financial Highlights
Key Financial Highlights • CSK financial performance from 2002 -2004 – Reported revenue, gross profit and Adjusted EBITDA increased annually – Cash flow from operations increased at a 35% CAGR – Debt was reduced by $62.5 million • Financial performance has declined in 2005 and YTD 2006 – The decline
Slide 21: Reported Historical Financial Summary
Reported Historical Financial Summary Historical Financial Summary ($ in millions) Fiscal Year End LTM 2002 2003 2004 2005 7/2/2006 Total Net Sales $781.8 $885.6 $1,031.7 $1,042.0 $1,012.7 % Growth n/a 13.3% 16.5% 1.0% n/a Total Gross Profit 141.8 163.4 173.3 176.5 169.8 % Margin 18.1% 18.5% 16.8% 1
Slide 22: Paperboard Business Segment
Paperboard Business Segment Revenue Adjusted EBITDA $120 $1,000 $104.0 $864.7 $860.2 $99.0 $846.5 $96.6 $90.5 $753.4 $90 $750 $500 $60 $250 $30 $0 $0 FY '03 FY '04 FY '05 LTM 7/2/06 FY '03 FY '04 FY '05 LTM 7/2/06 Based on 2003 exchange rates FX Impact Based on 2003 exchange rates FX Impact • Adjust
Slide 23: Plastics Business Segment
Plastics Business Segment Revenue Adjusted EBITDA $200 $32 $181.8 $167.0 $166.2 $26.0 $24.6 $24.3 $150 $22.6 $132.2 $24 $100 $16 $50 $8 $0 $0 FY '03 FY '04 FY '05 LTM 7/2/06 FY '03 FY '04 FY '05 LTM 7/2/06 Based on 2003 exchange rates FX Impact Based on 2003 exchange rates FX Impact • Adjusted EBITD
Slide 24: Normalized Performance
Normalized Performance Normalized Performance ($ in millions) Fiscal Years Ended LTM 2003 2004 2005 7/2/2006 Adjusted EBITDA $110.7 $108.9 $104.4 $98.9 (1) Foreign exchange impact - (12.8) (12.2) (9.0) (1) Pension increase over 2003 - 4.2 9.2 12.8 (1) French luxury packaging (income) loss (0.5) 2.4
Slide 25: Proactive Management of Legacy Pension Obligations
Proactive Management of Legacy Pension Obligations • Proactive management of legacy obligations • US Plan benefits frozen 12/05, UK Plan frozen to new entrants 12/05 • Reduced UK benefits level for new entrants in 2004 • Increased UK employer and employee contribution rates in 2004 • Rising discount
Slide 26: Cash Flow & Profitability Initiatives
Cash Flow & Profitability Initiatives 26
Slide 27: Cost Savings Initiative
Cost Savings Initiative • Publicly announced $25 million annual cost savings initiative – Two year implementation period: 2006 - 2007 – Estimated cost of $30 - $40 million pre-tax • Sale or closure of underperforming / underutilized assets • General workforce reduction • Process improvement and over
Slide 28: Cost Savings Initiative: Progress to Date
Cost Savings Initiative: Progress to Date • Completed the closure of the Birmingham facility (food and household) in April 2006 – Severance benefits have been paid to approximately 190 employees • Sold the Lurgan facility (food and beverage) in March 2006 – Facility not viewed as a strategic fit • I
Slide 29: Cost Savings Initiative: On-going and Future Initiatives
Cost Savings Initiative: On-going and Future Initiatives • On-going and future initiatives include: – Additional Facility Rationalizations – Additional Workforce Reduction – Additional Process Improvement Initiatives • The global $25 million initiative represents identifiable costs that have been, o
Slide 30: #1 Focus is to Increase Cash Flow & Profitability
#1 Focus is to Increase Cash Flow & Profitability Cost Savings Program - $25 million Cost of Capital - Refinancing resulting in $3 million plus in annual interest savings Proactive Management of Legacy Pension Obligations Increased Organic Growth - Worldwide Cash Flow pharmaceutical packaging demand
Slide 31: Comparison of Debt Breakdown
Comparison of Debt Breakdown Debt Currency Mix Fixed vs. Variable Debt 100% 100% Variable, 7% USD, 12% Variable, 32% USD, 35% 75% 75% Euro, 29% 50% Euro, 29% 50% Fixed, 93% Fixed, 68% Sterling, 59% 25% 25% Sterling, 36% 0% 0% Reported 7/2/06 Proforma for transaction Reported 7/2/06 Proforma for tran
Slide 32: Debt Maturity Schedule
Debt Maturity Schedule $200 Pro Forma for Transaction 150 100 $123 $122 $128 50 $50 $22 $5 $5 $3 $5 $3 0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2019 Senior Debt Subordinated Debt 32
Slide 33: Conclusion / Q&A
4 - ~~ Conclusion / Q&A
Slide 34: Conclusion / Q&A
Conclusion / Q&A • Market leadership position in targeted markets • Comprehensive design and manufacturing capabilities • Global manufacturing presence – strategically located • Long-term customer relationships (top ten average > 30 years) • Designated as “Primary Supplier” to many of its customers
Slide 35: Credit Facilities
4 (4 -t Credit Facilities
Slide 36: Sources & Uses
Sources & Uses • Current: Refinance the existing credit facilities and pay fees and expenses associated with the Credit Facilities • November 15th: Fund the Delayed Draw Term Loan with proceeds utilized to call the Notes and pay the associated call premium of 105.1875% Sources Uses ($ in millions) R
Slide 37: Pro Forma Capitalization
Pro Forma Capitalization • Holding debt constant, leverage is reduced to 3.8x utilizing the $25 million savings targeted Pro Forma Capitalization ($ in millions) Pro Forma At Close 7/2/06 Cumulative Pro Forma Post Redemption Cumulative Cumulative (4) (5) Book Capitalization Multiple of Book Capitali
Slide 38: Summary Terms
Summary Terms BORROWER: Chesapeake Corporation and various foreign subsidiary borrowers SOLE BOOKRUNNER: Wachovia Capital Markets, LLC CO-LEAD ARRANGERS: Wachovia Capital Markets, LLC and Banc of America Securities LLC FACILITIES: $125 million 5-Year Revolving Credit Facility £70 million 7-Year Term
Slide 39: Appendix
of ia ~“ Appendix
Slide 40: Financial Reconciliations
Financial Reconciliations Reconciliation of Adjusted EBITDA and Adjusted EBIT to EBIT ($ in millions) Year-Ended LTM December 29, December 28, January 2, January 1, July 2, 2002 2003 2005 2006 2006 Sales from continuing operations: Paperboard Packaging $678.1 $753.4 $864.7 $860.2 $846.5 Plastic Pack
Slide 41: Chesapeake Corp. Lender Presentation
Chesapeake Corp. Lender Presentation 41 August 9, 2006
Chesapeake — Debt Investor Presentation (August 2006) on 6ix